The Journal of Clinical Endocrinology and Metabolism. Hall GM, Hunter JM, Cooper MS (2010). Core Topics in Endocrinology in Anaesthesia and important Care. Cambridge University Press. p. Canadian Journal of Ophthalmology. Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M (March 2018). "2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction". Venturi S (2011). "Evolutionary Significance of Iodine". Venturi S (2014). "Iodine, PUFAs and Iodolipids in Health and Disease: An Evolutionary Perspective". Ylli D, Wartofsky L, Burman KD (January 2021). "Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders". Chew E, Ghosh M, McCulloch C (June 1982). "Amiodarone-induced cornea verticillata". 106 (1): 226-236. doi:10.1210/clinem/dgaa686. The American Journal of Medicine. Batcher EL, Tang XC, Singh BN, Singh SN, Reda DJ, Hershman JM (October 2007). "Thyroid perform abnormalities during amiodarone therapy for persistent atrial fibrillation". 100 (1): E1-10. doi:10.1210/jc.2014-2745. The Journal of Clinical Endocrinology and Metabolism. Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, et al.Cureus. 15 (3) e36818. Tsang W, Houlden RL (July 2009). "Amiodarone-induced thyrotoxicosis: a evaluate". Duineveld MD, Kers J, Vleming LJ (September 2023). "Case report of progressive renal dysfunction as a consequence of amiodarone-induced phospholipidosis". 7 (9) ytad457. doi:10.1093/ehjcr/ytad457. Lombardi A, Inabnet WB, Owen R, Farenholtz KE, Tomer Y (January 2015). "Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis". December 2022). "Pulmonary Fibrosis Related to Amiodarone-Is It a regular Pathophysiological Pattern? A Case-Based Literature Review". Diagnostics. 12 (12): 3217. doi:10.3390/diagnostics12123217. Florek JB, Lucas A, Girzadas D (2024). Amiodarone. viagra nasal congestion , Huang LT, Yu YT, Lee CT, Huang TH (June 2023). "Variable radiographic and histologic displays of amiodarone-related interstitial lung disease and the significance of avoiding re-exposure". Budin CE, Cocuz IG, Sabău AH, Niculescu R, Ianosi IR, Ioan V, et al. Can J Cardiol. 25 (7): 421-4. doi:10.1016/s0828-282x(09)70512-4. Eur Heart J Case Rep. Mitrofan CE, Cretu A, Mitrofan C, Bar C, Ghiciuc CM (2022). "Amiodarone induced lung disease". Respirol Case Rep. Eleven (6) e01165. PMID 29489285. NCBI NBK482154.This is partially supported by dronedarone which is noniodinated benzofuran derivative of amiodarone, where the arylmethanone is conserved. Orally, it is accessible below the brand names Pacerone (produced by Upsher-Smith Laboratories, Inc.) and Cordarone (produced by Wyeth-Ayerst Laboratories). Amiodarone is available in oral and intravenous formulations. It is also accessible underneath the model title Aratac (produced by Alphapharm Pty Ltd) in Australia and New Zealand, and additional in Australia below the brands Cardinorm and Rithmik in addition to quite a few generic brands. When administered orally, the bioavailability of amiodarone is sort of variable. It's also obtainable in intravenous ampules and vials. The dose of amiodarone administered is tailored to the individual and the dysrhythmia that's being treated. Also Arycor in South Africa (Produced by Winthrop Pharmaceuticals.). Absorption ranges from 22 to 95%, with better absorption when it is given with meals. In South America, it is known as Atlansil and is produced by Roemmers. In India, amiodarone is marketed (produced by Cipla Pharmaceutical) beneath the model identify Tachyra.Current Opinion in Drug Discovery & Development. British Heart Journal. 8 (4): 171-177. doi:10.1136/hrt.8.4.171. 2005). Goodman & Gilman's The Pharmacological Basis of Therapeutics (eleventh ed.). Di L, Balesano A, Jordan S, Shi SM (January 2021). "The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation". Brunton LL, Lazo JS, Parker K, eds. Deltour G, Binon F, Tondeur R, Goldenberg C, Henaux F, Sion R, et al. 1986). Amiodarone: pharmacology, pharmacokinetics, toxicology, clinical effects. The American Journal of Cardiology. Paris: Médecine et sciences internationales. U.S. Food and Drug Administration. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, et al. Shleghm MR, Mircioiu C, Voicu VA, Mircioiu I, Anuta V (2020). "Estimation of the In Vivo Release of Amiodarone From the Pharmacokinetics of Its Active Metabolite and Correlation With Its In Vitro Release". Singh BN, Vaughan Williams EM (August 1970). "The impact of amiodarone, a brand new anti-anginal drug, on cardiac muscle". Latini R, Tognoni G, Kates RE (April 1984). "Clinical pharmacokinetics of amiodarone". Harris L, Williams RR, eds. British Journal of Pharmacology. Rosenbaum MB, Chiale PA, Haedo A, Lázzari JO, Elizari MV (October 1983). "Ten years of expertise with amiodarone". Anrep GV, Barsoum GS, Kenawy MR, Misrahy G (October 1946). "Ammi Visnaga within the Treatment of the Anginal Syndrome". Archives Internationales de Pharmacodynamie et de Therapie (in French). December 1976). "Clinical efficacy of amiodarone as an antiarrhythmic agent". Herzschrittmacherther Elektrophysiol (in German). Archives Internationales de Pharmacodynamie et de Therapie (in French). Antiarrhythmic Agents. Books LLC. Ghovanloo MR, Abdelsayed M, Ruben Pc (2016). "Effects of Amiodarone and N-desethylamiodarone on Cardiac Voltage-Gated Sodium Channels".